OMS906 study drug

Drug identity checked against registry records

Also recorded as OMS906

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal HemoglobinuriaNCT06298955Omeros CorporationPhase 2Active not recruiting2026-12Estimated
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNNCT06209736Omeros CorporationPhase 2Terminated2026-04-14Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.